Live Breaking News & Updates on பரிமாற்றம் ஆன் ஜான்
Stay updated with breaking news from பரிமாற்றம் ஆன் ஜான். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Microsoft Released Patches for 4 Exploited Zero-Day Flaws bankinfosecurity.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bankinfosecurity.com Daily Mail and Mail on Sunday newspapers.
Microsoft Released Patches for 4 Exploited Zero-Day Flaws govinfosecurity.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from govinfosecurity.com Daily Mail and Mail on Sunday newspapers.
Serious vulnerabilities in Microsoft Exchange have been exploited by at least 10 APT groups that have been collectively been hitting thousands of companies over the ....
Microsoft Exchange attack timeline (Source: ESET) Serious vulnerabilities in Microsoft Exchange have been exploited by at least 10 advanced persistent threat groups that have been collectively been hitting thousands of companies over the last three months, security researchers warn. Full details of the attacks and groups involved - when known - have been released by researchers at Slovakia-based security firm ESET. They say at least several APT groups also began attacks that exploit the flaws, prior to Jan. 5, which is when Microsoft says it first learned about the vulnerabilities. This suggests that multiple threat actors gained access to the details of the vulnerabilities before the release of the patch, which means we can discard the possibility that they built an exploit by reverse-engineering Microsoft updates, ESET researchers say. ....
The Globe and Mail Jameson Berkow Published March 2, 2021 Moha El-Jaw/iStockPhoto / Getty Images Could the burgeoning psychedelics sector end up spawning a major stock rally that could dwarf the cannabis-driven market mayhem of the past decade? According to Maruf Raza, a partner and national director of public companies at MNP LLP in Toronto, “From a market perspective, you could argue the blue-sky opportunity for psychedelics is far, far greater [than for cannabis].” Mr. Raza is part of a growing group of market watchers expecting vast sums of money to pour into companies studying psilocybin, ketamine, LSD and other so-called “hard drugs” for medical purposes. But because the nascent sector is largely organized around disrupting the global anti-depressant market, which is worth tens of billions of dollars annually to pharmaceutical giants, investors see less policy risk. ....